Enliven Therapeutics, Inc. (ELVN)
49.45
-0.79
(-1.57%)
USD |
NASDAQ |
Sep 18, 16:00
49.45
0.00 (0.00%)
After-Hours: 20:00
Enliven Therapeutics Cash from Investing (Quarterly) : -441.57M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -441.57M |
| March 31, 2026 | 42.53M |
| December 31, 2025 | 12.38M |
| September 30, 2025 | -4.058M |
| June 30, 2025 | -183.59M |
| March 31, 2025 | 1.427M |
| December 31, 2024 | 0.727M |
| September 30, 2024 | 14.83M |
| June 30, 2024 | -33.66M |
| March 31, 2024 | -17.88M |
| December 31, 2023 | 38.69M |
| September 30, 2023 | -35.55M |
| June 30, 2023 | -151.52M |
| March 31, 2023 | -0.031M |
| Date | Value |
|---|---|
| December 31, 2022 | 77.03M |
| September 30, 2022 | -0.014M |
| June 30, 2022 | -0.303M |
| March 31, 2022 | -0.194M |
| December 31, 2021 | -14.49M |
| September 30, 2021 | -8.832M |
| June 30, 2021 | 3.388M |
| March 31, 2021 | 18.30M |
| December 31, 2020 | 21.21M |
| September 30, 2020 | -10.28M |
| June 30, 2020 | -32.41M |
| March 31, 2020 | 4.757M |
| December 31, 2019 | -2.112M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Definium Therapeutics, Inc. | -315.46M |
| Cocrystal Pharma, Inc. | 0.00 |
| CNBX Pharmaceuticals, Inc. | 0.00 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 54.90M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.53M |
| Cash from Financing (Quarterly) | 463.42M |
| Free Cash Flow | -67.04M |
| Free Cash Flow Per Share (Quarterly) | -0.2815 |
| Free Cash Flow to Equity (Quarterly) | -19.84M |
| Free Cash Flow to Firm (Quarterly) | -18.63M |
| Free Cash Flow Yield | -2.14% |